Company intelligence / Profile preview

VivoRx

Santa Monica / Los Angeles area, California, United Statesen.wikipedia.org ↗

Ownership: Private
Development stage: Phase 1

Overview

VivoRx was an inactive biopharmaceutical company focused on developing encapsulated islet cell therapies for insulin-dependent diabetes, reaching Phase 1/2 clinical trials. It was a wholly-owned subsidiary of Abraxis BioScience and is now defunct.

Therapeutic areas: Endocrinology
Modalities: Cell therapyBiologic delivery systems
Industry: Biotech

Drug pipeline

1 asset

Encapsulated islet cells

Phase 1

Indications: Type 1 diabetes

Partnerships

Mylan Laboratories (exclusive license to market the company's diabetes control technology during its development phase)

Beyond the preview

Go deeper on VivoRx.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VivoRx.

Explore the full profile